HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ALMANAC Trialists Group Selected Research

sulfan blue (patent blue V)

9/2006Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
1/2005Role of routine preoperative lymphoscintigraphy in sentinel node biopsy for breast cancer.
10/2004Internal mammary node drainage and its role in sentinel lymph node biopsy: the initial ALMANAC experience.
7/2004Predictors of non-sentinel lymph node metastasis in breast cancer patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


ALMANAC Trialists Group Research Topics

Disease

5Breast Neoplasms (Breast Cancer)
09/2006 - 06/2004
1Neoplasms (Cancer)
10/2004

Drug/Important Bio-Agent (IBA)

5Coloring Agents (Dyes)IBA
09/2006 - 06/2004
4sulfan blue (patent blue V)IBA
09/2006 - 07/2004
2Colloids (Colloid)IBA
09/2006 - 06/2004
1RadiopharmaceuticalsIBA
09/2006
1Technetium Tc 99m Aggregated AlbuminIBA
10/2004
1Technetium (Technetium 99m)IBA
10/2004

Therapy/Procedure

1Therapeutics
10/2004
1Adjuvant Chemotherapy
10/2004
1Lymph Node Excision (Lymph Node Dissection)
06/2004
1Contraindications
06/2004